Estrogen is a principal regulator of epiphyseal fusion in females and males. Mauras et al ... with the selective aromatase inhibitor anastrozole, administered to growth hormone (GH)-deficient ...

Burnett-Bowie et al. investigated the efficacy and safety of the synthetic aromatase inhibitor anastrozole to treat hypogonadism in aging men. The study enrolled 88 men (60 years or older ...

A new study published in The Lancet Oncology discusses the efficacy of anastrozole, a molecule used to prevent breast cancer in postmenopausal women with a high risk of breast cancer. Breast ...

Anastrozole, used for many years to treat the disease, has now been licensed as a preventative option. Recent trials show the drug can reduce the incidence of breast cancer by almost 50% in post ...

Anastrozole blocks the production of the hormone oestrogen, which fuels the growth of many breast cancers. It is already available on the NHS, but researchers at Queen Mary University of London ...

Exceptions: Pre-operative aromatase therapy (anastrozole, letrozole, or exemestane) and last treatment was ≥ 4 weeks prior to registration; OR Pre-operative tamoxifen therapy and last treatment was ≥ ...